Loading data for CANC — first visit, this takes a few seconds.
Tema Oncology ETF (CANC)
NasdaqGM: CANC
· Real-Time Price · USD
44.05
+0.34 (0.78%)
At close: Sep 04, 2026, 8:00 PM
44.11
+0.14%
After-hours: 7:30 PM
The price, the headline numbers and the latest news, in one place.
Tema Oncology ETF (CANC) Stock Price, Analysis & Data
No data available
| Bid | 41.61 |
| Market Cap | n/a |
| Revenue (ttm) | n/a |
| Net Income (ttm) | n/a |
| 0.00 | |
| n/a | |
| 27.71 | |
| n/a | |
| P/B (ttm) | 0.00 |
| P/S (ttm) | 0.00 |
| Earnings Date | n/a |
| Ask | 42.11 |
| Volume | 15,624 |
| Avg. Volume (20D) | 32,585 |
| Open | 43.99 |
| Previous Close | 43.71 |
| Day's Range | 43.66 - 44.79 |
| 52-Week Range | 26.62 - 47.00 |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About CANC
Under normal circumstances, the fund seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in publicly listed companies that derive at least 50% of revenues from oncology. The fund is non-diversified....
Industry n/a
Sector n/a
IPO Date Aug 14, 2023
Employees n/a
Stock Exchange NasdaqGM
Ticker Symbol CANC
Financial Performance
In undefined, Tema Oncology ETF's revenue was n/a, an increase of undefined% compared to the previous year's n/a. Earnings were n/a, an increase of undefined%.
Financial StatementsEarnings Surprise
Tema Oncology ETF has released their quarterly earnings on Invalid Date:
- Revenue of n/a misses estimates by $0, with NaN% YoY growth.
- EPS of misses estimates by , with NaN% YoY growth.
